Abstract Monoclonal antibodies (mAbs) and bispecific antibodies (bsAbs) have transformed therapeutic strategies for various diseases. However, administering them can lead to unwanted adverse effects and insufficient delivery to local disease sites.
Akifumi Kato +7 more
wiley +1 more source
Japanese clinical guidelines for neovascular age-related macular degeneration. [PDF]
Iida T +7 more
europepmc +1 more source
The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: A review based on controversial evidence [PDF]
Maneli Mozaffarieh +2 more
openalex +1 more source
Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?
Abstract Gyrate atrophy of the choroid and retina (GACR; OMIM #258870) is a rare early‐onset autosomal recessive disorder, caused by bi‐allelic pathogenic variants in the gene coding for ornithine aminotransferase (OAT) resulting in hyperornithinaemia.
Mark J. N. Buijs +12 more
wiley +1 more source
Are surfers and scuba divers an overlooked at-risk group for age-related macular degeneration? [PDF]
Beaver D, Hudson C.
europepmc +1 more source
Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration [PDF]
Xiaorong Gu +6 more
openalex +1 more source
Preservatives in artificial tears: Assessing impact on dry eye symptoms
Abstract Purpose To examine the association between the presence of dry eye disease (DED) symptoms when using BAK‐preserved artificial tears (AT) compared to preservative‐free AT. Methods In this cross‐sectional study, we used data collected as part of Project ‘Finding Ophthalmic Risk and Evaluating the Value of Eye exams and their predictive ...
Astrid Dissing Sjö +3 more
wiley +1 more source
Efdamrofusp alfa: an insight into the novel drug and its use in age-related macular degeneration. [PDF]
Rath S +7 more
europepmc +1 more source
Abstract The aim of this review was to evaluate the comparative efficacy of intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) therapy for neovascular AMD. We searched 12 literature databases for randomised clinical trials (RCT) on anti‐VEGF therapy for neovascular AMD and extracted data on: change from baseline to 12 months in best ...
Emilie T. S. Butler +17 more
wiley +1 more source
Age-related macular degeneration associated with optic disc drusen. [PDF]
Alkhabaz A +6 more
europepmc +1 more source

